• Emmanuel Bourinet, Amaury Francois, and Sophie Laffray.
• aLaboratories of Excellence, Ion Channel Science and Therapeutics, Institut de Génomique Fonctionnelle, Montpellier, FrancebCNRS UMR5203, Montpellier, FrancecINSERM, U661, Montpellier, FrancedUniversité de Montpellier, Montpellier, FranceeDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford Neurosciences Institute, Palo Alto, CA, USA.
• Pain. 2016 Feb 1; 157 Suppl 1: S15-22.

AbstractPain is a quite frequent complaint accompanying numerous pathologies. Among these pathological cases, numerous neuropathies are retrieved with identified etiologies (chemotherapies, diabetes, surgeries…) and also more diffuse syndromes such as fibromyalgia. More broadly, pain is one of the first consequences of most inherited diseases. Despite its importance for the quality of life, current pain management is limited to drugs that are either old or with a limited efficacy or that possess a bad risk benefit ratio. As no new pharmacological concept has led to new analgesics in the last decades, the discovery of new medications is needed, and to this aim, the identification of new druggable targets in pain transmission is a first step. Therefore, studies of ion channels in pain pathways are extremely active. This is particularly true with ion channels in peripheral sensory neurons in dorsal root ganglia known how to express unique sets of these channels. Moreover, both spinal and supraspinal levels are clearly important in pain modulation. Among these ion channels, we and others revealed the important role of low voltage-gated calcium channels in cellular excitability in different steps of the pain pathways. These channels, by being activated nearby resting membrane potential, have biophysical characteristics suited to facilitate action potential generation and rhythmicity. In this review, we will present the current knowledge on the role of these channels in the perception and modulation of pain.

12 keywords...

hide…